103 results
424B3
ZVRA
Zevra Therapeutics Inc
10 Apr 24
Prospectus supplement
4:23pm
by or on behalf of us or to which we have referred you. We and the selling stockholders take no responsibility for, and can provide no assurance
424B5
ZVRA
Zevra Therapeutics Inc
21 Nov 23
Prospectus supplement for primary offering
7:40pm
you with different information. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others … bank or trust company may act as warrant agent for more than one issue of warrants. A warrant agent will have no duty or responsibility in case of any
8-K
EX-99.2
z7gck91 8anl2etp5wn
20 Nov 23
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
7:36am
8-K
EX-10.1
w41jgn eelsn9m
20 Nov 23
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
7:36am
8-K
iuskyt7xyt egpes1ky
10 Oct 23
Departure of Directors or Certain Officers
5:12pm
424B3
aw23q43fo xyb
10 Oct 23
Prospectus supplement
5:07pm
S-4/A
23y2a
6 Oct 23
Registration of securities issued in business combination transactions (amended)
4:06pm
S-4
3nu14ura qs
28 Sep 23
Registration of securities issued in business combination transactions
9:25pm
425
whb3gzxkpfkqdoqkw8qa
31 Aug 23
Business combination disclosure
8:03am
8-K
EX-2.1
dtfcwp42
31 Aug 23
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
8:01am
8-K
EX-10.3
z48halm26 73sasrt
31 Aug 23
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
8:01am
8-K
EX-10.2
sti0frttje5w
31 Aug 23
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
8:01am
8-K
EX-10.1
bu075l 2ss
31 May 22
Entry into a Material Definitive Agreement
9:13pm
424B3
poxbtmazpq90l
2 Feb 22
Prospectus supplement
4:16pm
POS AM
0xg5hquyy9
25 Jan 22
Prospectus update (post-effective amendment)
4:56pm